Conmed (CNMD) Surpasses Q4 Earnings and Revenue Estimates

Group 1 - Conmed reported quarterly earnings of $1.34 per share, exceeding the Zacks Consensus Estimate of$1.20 per share, and up from $1.06 per share a year ago, representing an earnings surprise of 11.67$345.94 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 1.36%, compared to 327.05 million in the same quarter last year [2] - Conmed has outperformed the S&P 500, with shares increasing about 6.5% since the beginning of the year, while the S&P 500 gained 2.7% [3] Group 2 - The current consensus EPS estimate for the upcoming quarter is 1 on revenues of $334.22 million, and for the current fiscal year, it is$4.71 on revenues of $1.4 billion [7] - The Zacks Industry Rank indicates that the Medical - Dental Supplies sector is currently in the bottom 40% of over 250 Zacks industries, which may impact stock performance [8]